Detalhe da pesquisa
1.
Western diet increases brain metabolism and adaptive immune responses in a mouse model of amyloidosis.
J Neuroinflammation
; 21(1): 129, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38745337
2.
Presenilin-1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage.
Alzheimers Dement
; 20(4): 2680-2697, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38380882
3.
T1 and FLAIR signal intensities are related to tau pathology in dominantly inherited Alzheimer disease.
Hum Brain Mapp
; 44(18): 6375-6387, 2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37867465
4.
Noninvasive Detection of Smooth Muscle Cell-Derived Hot Spots to Study Atherosclerosis by PET/MRI in Mice.
Circ Res
; 132(6): 747-750, 2023 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36794593
5.
Simultaneous whole-body PET/MRI with integrated multiparametric MRI for primary staging of high-risk prostate cancer.
World J Urol
; 38(10): 2513-2521, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31907632
6.
Fast enzymatic synthesis of n.c.a. 6-[18 F]fluorodopamine (FDA) from n.c.a. 6-[18 F]FDOPA and the fate of 6-FDOPA and 6-FDA in neuroblastoma and Caki-1 cells after their uptake.
J Labelled Comp Radiopharm
; 62(8): 438-447, 2019 06 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31090094
7.
Evaluation of the therapeutic potential of the selective p38 MAPK inhibitor Skepinone-L and the dual p38/JNK 3 inhibitor LN 950 in experimental K/BxN serum transfer arthritis.
Inflammopharmacology
; 27(6): 1217-1227, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31037574
8.
Glioma grading by dynamic susceptibility contrast perfusion and 11C-methionine positron emission tomography using different regions of interest.
Neuroradiology
; 60(4): 381-389, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29464269
9.
64Cu antibody-targeting of the T-cell receptor and subsequent internalization enables in vivo tracking of lymphocytes by PET.
Proc Natl Acad Sci U S A
; 112(4): 1161-6, 2015 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-25587131
10.
Fast non-enhanced abdominal examination protocols in PET/MRI for patients with neuroendocrine tumors (NET): comparison to multiphase contrast-enhanced PET/CT.
Radiol Med
; 123(11): 860-870, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29961229
11.
Characterization of a novel murine model for spontaneous hemorrhagic stroke using in vivo PET and MR multiparametric imaging.
Neuroimage
; 155: 245-256, 2017 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28473286
12.
Comparison of 68Ga-labelled PSMA-11 and 11C-choline in the detection of prostate cancer metastases by PET/CT.
Eur J Nucl Med Mol Imaging
; 44(1): 92-101, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27557844
13.
Overlap of highly FDG-avid and FMISO hypoxic tumor subvolumes in patients with head and neck cancer.
Acta Oncol
; 56(11): 1577-1582, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28849721
14.
Geometric analysis of loco-regional recurrences in relation to pre-treatment hypoxia in patients with head and neck cancer.
Acta Oncol
; 56(11): 1571-1576, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28891398
15.
No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigra.
Brain
; 138(Pt 11): 3316-26, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26362908
16.
Robustness of quantitative hypoxia PET image analysis for predicting local tumor control.
Acta Oncol
; 54(9): 1364-9, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26481464
17.
Assessment of rodent brain activity using combined [(15)O]H2O-PET and BOLD-fMRI.
Neuroimage
; 89: 271-9, 2014 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24316549
18.
CD19-immunoPET for noninvasive visualization of CD19 expression in B-cell lymphoma patients.
Biomark Res
; 12(1): 50, 2024 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38735945
19.
A novel approach to guide GD2-targeted therapy in pediatric tumors by PET and [64Cu]Cu-NOTA-ch14.18/CHO.
Theranostics
; 14(3): 1212-1223, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38323317
20.
Radiosensitizing Favors Response to Peptide Receptor Radionuclide Therapy in Patients With Highly Proliferative Neuroendocrine Malignancies: Preliminary Evidence From a Clinical Pilot Study.
Clin Nucl Med
; 49(3): 207-214, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38271237